According to Facts and Factors, the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market size was worth at around USD 1.4 billion in 2021 and is estimated to grow about USD 2.5 billion by 2028, at a CAGR of approximately 8.5% between 2022 and 2028. The key players are covered in the report are Olympus Corporation, CONMED Corporation, HOYA Corporation, Fujifilm Holdings Corporation, KARL STORZ SE & Co. KG, Ambu A/S, Johnson & Johnson, Boston Scientific Corporation, Medtronic, PLC, Cook Medical, B. Braun Melsungen AG, and others.
Miami, FL, Oct. 07, 2022 (GLOBE NEWSWIRE) -- According toFacts and Factors has published a new research report titled “Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Size, Share, Growth Analysis Report By Product (Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others), By Application (Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Sphincterotomy, Pancreatic Duct Stenting, and Pancreatic Duct Dilatation), By End-User (Hospitals & Clinics, Ambulatory Surgery Centers and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” in its research database.
The report analyzes the global Endoscopic Retrograde Cholangiopancreatography (ERCP) market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Endoscopic Retrograde Cholangiopancreatography (ERCP) market.
An endoscope is inserted into the second part of the duodenum during the combination fluoroscopic and endoscopic operation known as endoscopic retrograde cholangiopancreatography (ERCP). This allows other tools to be inserted into the biliary and pancreatic ducts through the crucial duodenal papilla. To detect and treat pancreaticobiliary diseases, ERCP devices combine luminal endoscopy and fluoroscopic imaging.
These tools are inserted via the esophagus and the stomach into the stomach portion of the duodenum using a side-view duodenoscopy. Devices for endoscopic retrograde cholangiopancreatography (ERCP) are primarily used to treat blocked bile or pancreatic ducts or to extract samples of cells and tissues.
Click Here To Access Free Sample Report of the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market @ https://www.fnfresearch.com/sample/endoscopic-retrograde-cholangiopancreatography-ercp-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
Provide detailed chapter-by-chapter guidance on Request
Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
Includes Tables and figures have been updated
The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Facts and Factors research methodology
Market Growth Drivers
Growing application of ERCP to drive the market growth during the forecast period
The high prevalence of chronic disorders like Crohn's disease, Barrett's disease, and pancreatic cancer around the world, together with government measures to raise patient knowledge of better and more cutting-edge therapies, are driving the global endoscopic retrograde cholangiopancreatography (ERCP) market's expansion.
The high cost of ERCP devices is projected to hamper the market growth
The strict government regulations imposed by regulatory organizations in many countries for the introduction of new technologies are limiting the market's expansion. The market is benefiting from the rising disposable income, particularly in developing nations where consumers are becoming more aware of cutting-edge technology. The high expense of the treatment could be a barrier to the market's expansion.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/endoscopic-retrograde-cholangiopancreatography-ercp-market
The global endoscopic retrograde cholangiopancreatography (ERCP) market is segmented based on product, application, end-user, and region.
The global market is divided into endoscopes, endotherapy devices, visualization systems, energy devices, and others based on the product. The market's largest contributor, the endoscopes segment, is expected to expand at a CAGR of 8.9% during the projected period. The market for endoscopic retrograde cholangiopancreatography devices for endoscopes is anticipated to grow significantly over the next few years as a result of an increase in gastrointestinal and chronic biliary problems. The World Health Organization estimates that gastrointestinal (GI) illnesses are responsible for about 8 million deaths each year. As a result, it is projected that there would be a rise in conditions linked to pancreatic cancer and the bile duct liver. Additionally, it opens up a huge window of opportunity for producers of endoscopic retrograde cholangiopancreatography devices to grow their brands internationally. In the upcoming years, it is also projected that rising health care costs and advantageous administrative rules will spur market expansion.
The global market is bifurcated into biliary sphincterotomy, biliary stenting, biliary dilatation, pancreatic sphincterotomy, pancreatic duct stenting, and pancreatic duct dilatation based on application. The market's largest contributor, biliary sphincterotomy, expanded at a CAGR of 8.1% over the projection period. After selective cannulation with a specialized tool called a sphincterotome introduced into the papilla, the biliary sphincter and the intraduodenal portion of the common bile duct are severed using a high-frequency current. Biliary sphincterotomy or biliary endoscopic sphincterotomy are the names of this surgery (EST).
Based on the end user, the global market is divided into hospitals & clinics, ambulatory surgery centers, and others. The market's largest contributor, the hospitals and clinics sector, is expected to rise at a CAGR of 7.8% during the projected period. Ambulatory surgery centers, or ASCs, are specialized medical facilities that give patients the choice to have surgeries and other treatments performed outside of a conventional hospital setting. Due to the high prevalence of pancreatic cancer, bile duct, and pancreatic duct illnesses, the segment for ambulatory surgical centers is anticipated to experience the highest growth during the projection period. These aspects are anticipated to encourage the ERCP market.
The global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is segmented as follows:
Pancreatic Duct Stenting
Pancreatic Duct Dilatation
By End User
Hospitals & Clinics
Ambulatory Surgery Centers
Browse the full “Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Size, Share, Growth Analysis Report - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/endoscopic-retrograde-cholangiopancreatography-ercp-market
The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards. Some of the main competitors dominating the global Endoscopic Retrograde Cholangiopancreatography (ERCP) market include -
Fujifilm Holdings Corporation
KARL STORZ SE & Co. KG
Johnson & Johnson
Boston Scientific Corporation
B. Braun Melsungen AG.
Key Insights from Primary Research:
According to the analysis shared by our research forecaster, the Endoscopic Retrograde Cholangiopancreatography (ERCP)market is likely to expand at a CAGR of around 8.5% during the forecast period (2022-2028).
In terms of revenue, the global Endoscopic Retrograde Cholangiopancreatography (ERCP) market size was valued at around USD 1.4 billion in 2021 and is projected to reach USD 2.5 billion, by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
Based on the product, the endoscopes segment held the largest market share in 2021.
Based on end users, the hospitals & Clinics segment accounted for the major market share in 2021 and is expected to show its dominance during the forecast period.
Based on region, North America is projected to dominate the market during the forecast period.
Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/endoscopic-retrograde-cholangiopancreatography-ercp-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
In 2021, the global endoscopic retrograde cholangiopancreatography market in North America held the highest share, accounting for 35% of the global market. This region is expanding as a result of intensive diagnostic imaging research and the rapid introduction of technologically advanced ERCP tools like sphincterotomes. The expansion of the endoscopic retrograde cholangiopancreatography market in the North American area is further fueled by the increase in government funding for healthcare and the presence of major players like Hobbs Medical Inc.
Furthermore, it is predicted that over the projected period, the Asia-Pacific region will experience the fastest CAGR rate. The healthcare industry's development is a contributing factor to this rise. The development of the Endoscopic Retrograde Cholangiopancreatography Market in the Asia-Pacific region is further fueled by the rising awareness regarding the treatment of pancreatic and liver disorders involving sphincterotomy.
Rest of North America
Rest of Europe
Rest of Asia Pacific
The Middle East & Africa
Rest of the Middle East & Africa
Rest of Latin America
In January 2022, Cook Medical launched an endoscopic clipping device, namely Instinct Plus, which is compatible with a duodenoscope and has applications for defect closure, anchoring procedures, and prophylactic clipping in the gastrointestinal (GI) tract.
Market Size in 2021
USD 1.4 Billion
Projected Market Size in 2028
USD 2.5 Billion
CAGR Growth Rate
Key Market Players
Olympus Corporation, CONMED Corporation, HOYA Corporation, Fujifilm Holdings Corporation, KARL STORZ SE & Co. KG, Ambu A/S, Johnson & Johnson, Boston Scientific Corporation, Medtronic, PLC, Cook Medical, B. Braun Melsungen AG, and others.
By Product, Application, End User, and Region
Major Regions Covered
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Request customized purchase options to meet your research needs.
Browse Other Related Research Reports from Facts & Factors:
Medical Device Market: https://www.fnfresearch.com/medical-device-market
Orthopedic Trauma Devices Market: https://www.fnfresearch.com/global-orthopedic-trauma-devices-market-by-product-type-1220
Cardiac POC Testing Devices Market: https://www.fnfresearch.com/cardiac-poc-testing-devices-market
Catheter Stabilization Device Market: https://www.fnfresearch.com/catheter-stabilization-device-market
Ophthalmic Ultrasound Device Market: https://www.fnfresearch.com/ophthalmic-ultrasound-device-market-by-type-a-scan
Global UV Infection Control Device Market: https://www.fnfresearch.com/uv-infection-control-device-market
About Facts & Factors:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Facts & Factors
USA: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999
Also Read Our Blogs: